Close

Washington Governor Inslee Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

May 13 2015
Governor Inslee signed Senate Bill 5935 into law on Monday. The Washington Senate passed the legislation in April with a vote of 47-1, preceded by a vote of 96-1 on the same bill in the House.

BIO and Aon Join Forces to Offer Members Executive Liability Protection through BIO Business Solutions

May 13 2015
By teaming up with Aon, we are able to offer our members state-of-the-art coverage enhancements specific for life sciences companies...

2015 BIO International Convention to Feature Expanded Innovation Zone with NIH and NSF Small Business Innovation Research Companies

May 11 2015
Washington, D.C. (May 11, 2015) – The Biotechnology Industry Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR) funded early-stage biomedical companies in an expanded Innovation Zone at the 2015 BIO International Convention®. The Innovation Zone companies, focused on drug discovery, diagnostics and other therapeutic platform technologies, will have dedicated exhibit space and participate in BIO One-on-One Partnering™. Select companies will make 15-minute company presentations in the BIO Business Forum. The Innovation Zone will also feature six universities funded under the prestigious NSF Accelerating Innovation Research Program (AIR). This select group will demonstrate advanced biomedical prototypes that are very close to commercialization stage.  

LanzaTech CEO Holmgren Selected to receive the 2015 BIO Rosalind Franklin Award

May 8 2015
Washington, D.C. (May 08, 2015) – The Biotechnology Industry Organization (BIO)  announced today  that  Dr. Jennifer Holmgren, Chief Executive Officer of the innovative carbon recycling company LanzaTech, has been selected by a committee of her peers to be the recipient of the 2015 BIO Rosalind Franklin Award. The Rosalind Franklin Award was established by BIO to honor an outstanding woman in the field of industrial biotechnology. 

Tennessee Governor Haslam Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

May 7 2015
BIO and Life Science Tennessee commend Governor Bill Haslam for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Applauds the Securities and Exchange Commission for Finalizing Tick Size Pilot Program

May 7 2015
Program will improve liquidity and enhance capital formation for emerging biotech companies

Georgia Governor Deal Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

May 7 2015
BIO and Georgia Bio commend Governor Nathan Deal for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Forges Strategic Partnership with Leading Publication on Industrial Biotechnology for its World Congress on Industrial Biotechnology

May 7 2015
The Biotechnology Industry Organization (BIO) announced today that the Industrial Biotechnology (Mary Ann Liebert, Inc., publishers) Journal will become the official publication for the BIO World Congress on Industrial Biotechnology. The 2015 World Congress on Industrial Biotechnology will be held July 19-22, 2015 at the Palais des congrès de Montréal in Montréal, Canada. 

GM Crops Help Ensure Global Food Security Through Higher Crop Yields

May 7 2015
Farmers around the world who use seeds improved with biotechnology continue to benefit economically while improving the environmental sustainability of their farming operations according to an updated global impacts study. The economic benefits for farmers who use genetically modified (GM) seeds amounted to an average of more than $122/hectare in 2013, according to the report “GM Crops: Global Socio-Economic and Environmental Impacts 1996-2013” released today by PG Economics.

RFS Policy Instability Has Chilled Advanced and Cellulosic Biofuel Investments, BIO Says

May 4 2015
EPA’s delays in rulemaking for the Renewable Fuel Standard (RFS) over the past two years have chilled necessary investment in advanced and cellulosic biofuels just as they reached commercial deployment. We find that the industry has experienced an estimated $13.7 billion shortfall in investment as a result.